The 4000th eye tumour patient treated with protons at HZB
Overview: Number of patients treated with prontons at HZB from 1998 to 2020. © HZB/S. Kodalle
On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.
For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.
"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB.
500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.
- Joint power instead of duplicate structures:Berlin’s research community is further advancing its research excellence by establishing a high-performance, cross-institutional infrastructure for data and AI. With a joint agreement signed on 18 September 2026, the Berlin University Alliance (BUA), the Helmholtz-Zentrum Berlin (HZB) and the Zuse Institute Berlin (ZIB) are paving the way for a joint data science and AI centre in Berlin-Dahlem and Adlershof.
- New technique could make MRI more preciseA team of researchers at the University of Stuttgart and HZB has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.
- New method shows how molecular switches are influenced by their neighborsResearchers at Friedrich Schiller University Jena and the Helmholtz Centre Berlin (HZB) have, for the first time, been able to directly observe how the environment surrounding a molecular switch influences its electronic structure. Molecular switches are molecules that can be switched between two states by external influences such as changes in temperature—similar to a switch with the positions »On« and »Off«. Such molecules are being investigated as potential building blocks for future data storage devices or sensor materials. Using magnetic-field-dependent terahertz spectroscopy, the researchers have now, for the first time, been able to distinguish whether neighbouring molecules in a material are in the same or different states. The results have been published in the journal »Angewandte Chemie International Edition«.